Skip to main content
. 2014 Oct 1;2(4):E256–E261. doi: 10.9778/cmajo.20140027

Figure 2:

Figure 2:

Prevalence of opioid, benzodiazepine and stimulant prescriptions triggering drug utilization review warnings of both double-doctoring and polypharmacy in Ontario before and after introduction of safety legislation and a monitoring program, January 2007 to May 2013.